Literature DB >> 12228853

Lack of rapid aldosterone effects on forearm resistance vasculature in health.

Prasad Gunaruwan1, Matthias Schmitt, Justin Taylor, Leong Lee, Allan Struthers, Michael Frenneaux.   

Abstract

OBJECTIVES: Systemic infusions of aldosterone cause an acute increase in systemic vascular resistance (SVR) in healthy subjects. It is not clear whether this is due to a direct effect on the vasculature or the result of increased sympathetic tone. We investigated the short-term effects of locally infused aldosterone on the forearm resistance bed.
METHODS: In this dose response study, we assessed the effects of incremental doses (10, 50, 100 ng/minute) of intrabrachial aldosterone on forearm blood flow (FBF), using conventional strain gauge plethysmography. Arterial blood pressure was monitored continuously, using finger photo- plethysmography. Forearm vascular resistance (FVR) was calculated. FBF and FVR were also measured in the non-infused arm. Changes in FBF and FVR in the infused arm were corrected for those occurring in the control arm.
RESULTS: Plasma aldosterone levels in the venous effluent of the infused arm increased in a dose-dependent fashion, from 113.3+/-17.9 pg/ml at baseline to 297.8+/-51.8 pg/ml at 10 ng/minute (p=<0.01), 743.9+/-105.9 pg/ml at 50 ng/min (p=<0.001 vs. baseline) and 1230.6+/-73.7 pg/ml at 100 ng/min (p=<0.0005 vs. baseline). Plasma concentrations of aldosterone in the control arm did not change significantly vs. baseline. The corrected FBF (+4.1+/-10.3%) and corrected FVR (+4.3+/-11.3%) did not change significantly even at peak infusion rates.
CONCLUSIONS: Local intra-arterial infusion of aldosterone had no acute effect on forearm resistance vessels in healthy male volunteers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228853     DOI: 10.3317/jraas.2002.013

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  7 in total

1.  Low doses of fludrocortisone and hydrocortisone, alone or in combination, on vascular responsiveness to phenylephrine in healthy volunteers.

Authors:  Bruno Laviolle; Erwan Donal; Pascale Le Maguet; Fabrice Lainé; Eric Bellissant
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

2.  Unraveling the mechanisms underlying the rapid vascular effects of steroids: sorting out the receptors and the pathways.

Authors:  Ross D Feldman; Robert Gros
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 3.  Genomic and rapid effects of aldosterone: what we know and do not know thus far.

Authors:  Milla Marques Hermidorff; Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

4.  Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite.

Authors:  Abdul R Maher; Sayqa Arif; Melanie Madhani; Khalid Abozguia; Ibrar Ahmed; Bernadette O Fernandez; Martin Feelisch; A G O'Sullivan; Arthur Christopoulos; Aaron L Sverdlov; Doan Ngo; Rustem Dautov; Philip E James; John D Horowitz; Michael P Frenneaux
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 5.  Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications.

Authors:  Noboru Toda; Sadanobu Nakanishi; Shinichi Tanabe
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

Review 6.  Endothelial Dysfunction in Primary Aldosteronism.

Authors:  Zheng-Wei Chen; Cheng-Hsuan Tsai; Chien-Ting Pan; Chia-Hung Chou; Che-Wei Liao; Chi-Sheng Hung; Vin-Cent Wu; Yen-Hung Lin
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

7.  Effects of bradykinin on venous capacitance in health and treated chronic heart failure.

Authors:  Prasad Gunaruwan; Abdul Maher; Lynne Williams; James Sharman; Matthias Schmitt; Ross Campbell; Michael Frenneaux
Journal:  Clin Sci (Lond)       Date:  2009-03       Impact factor: 6.124

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.